BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22834677)

  • 1. Shikonin and its derivatives: a patent review.
    Wang R; Yin R; Zhou W; Xu D; Li S
    Expert Opin Ther Pat; 2012 Sep; 22(9):977-97. PubMed ID: 22834677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect research progress of shikonin and its derivatives].
    Zhu MY; Wang RB; Zhou W; Li SS
    Yao Xue Xue Bao; 2012 May; 47(5):588-93. PubMed ID: 22812000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma.
    Rajasekar S; Park DJ; Park C; Park S; Park YH; Kim ST; Choi YH; Choi YW
    J Ethnopharmacol; 2012 Nov; 144(2):335-45. PubMed ID: 22995444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorhizon.
    An S; Park YD; Paik YK; Jeong TS; Lee WS
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1112-6. PubMed ID: 17157006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives.
    Zhang X; Cui JH; Meng QQ; Li SS; Zhou W; Xiao S
    Mini Rev Med Chem; 2018; 18(2):164-172. PubMed ID: 28245783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin derivatives protect immune organs from damage and promote immune responses in vivo in tumour-bearing mice.
    Long S; GuangZhi Y; BaoJie G; Wei X; YanYong H; YingLi W; Yang Z; LiHua L
    Phytother Res; 2012 Jan; 26(1):26-33. PubMed ID: 21538626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties and derivatives of shikonin-A review in recent years.
    Guo C; He J; Song X; Tan L; Wang M; Jiang P; Li Y; Cao Z; Peng C
    Pharmacol Res; 2019 Nov; 149():104463. PubMed ID: 31553936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pharmacology studies of shikonin derivatives.
    Chen X; Yang L; Oppenheim JJ; Howard MZ
    Phytother Res; 2002 May; 16(3):199-209. PubMed ID: 12164262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological function and evaluation of Shikonin in cancer therapy.
    Wang F; Yao X; Zhang Y; Tang J
    Fitoterapia; 2019 Apr; 134():329-339. PubMed ID: 30858045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.
    Cui XR; Tsukada M; Suzuki N; Shimamura T; Gao L; Koyanagi J; Komada F; Saito S
    Eur J Med Chem; 2008 Jun; 43(6):1206-15. PubMed ID: 17949858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
    Tandon VK; Kumar S
    Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of shikonin - a review of literature since 2002.
    Andújar I; Ríos JL; Giner RM; Recio MC
    Planta Med; 2013 Dec; 79(18):1685-97. PubMed ID: 24155261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases.
    Kim JY; Jeong HJ; Park JY; Kim YM; Park SJ; Cho JK; Park KH; Ryu YB; Lee WS
    Bioorg Med Chem; 2012 Mar; 20(5):1740-8. PubMed ID: 22300884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin derivatives inhibited LPS-induced NOS in RAW 264.7 cells via downregulation of MAPK/NF-kappaB signaling.
    Cheng YW; Chang CY; Lin KL; Hu CM; Lin CH; Kang JJ
    J Ethnopharmacol; 2008 Nov; 120(2):264-71. PubMed ID: 18835347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis.
    Wu Z; Wu LJ; Li LH; Tashiro S; Onodera S; Ikejima T
    J Asian Nat Prod Res; 2004 Sep; 6(3):155-66. PubMed ID: 15224412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells.
    Zhang Y; Qian RQ; Li PP
    Cancer Lett; 2009 Oct; 284(1):47-54. PubMed ID: 19419812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin derivatives for cancer prevention and therapy.
    Boulos JC; Rahama M; Hegazy MF; Efferth T
    Cancer Lett; 2019 Sep; 459():248-267. PubMed ID: 31132429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60 human premyelocytic leukemia cell line.
    Yoon Y; Kim YO; Lim NY; Jeon WK; Sung HJ
    Planta Med; 1999 Aug; 65(6):532-5. PubMed ID: 10483373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of shikonin, a phytocompound from Lithospermum erythrorhizon, on rat vascular smooth muscle cells proliferation and apoptosis in vitro].
    Zhang ZQ; Cao XC; Zhang L; Zhu WL
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1484-8. PubMed ID: 16061028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red pigment from Lithospermum erythrorhizon by supercritical CO2 extraction.
    Lee HY; Kim YJ; Kim EJ; Song YK; Byun SY
    J Cosmet Sci; 2008; 59(5):431-40. PubMed ID: 18841307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.